These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

174 related items for PubMed ID: 30640576

  • 1. GPR17 receptor modulators and their therapeutic implications: review of recent patents.
    Marucci G, Dal Ben D, Lambertucci C, Martí Navia A, Spinaci A, Volpini R, Buccioni M.
    Expert Opin Ther Pat; 2019 Feb; 29(2):85-95. PubMed ID: 30640576
    [Abstract] [Full Text] [Related]

  • 2. The orphan receptor GPR17 identified as a new dual uracil nucleotides/cysteinyl-leukotrienes receptor.
    Ciana P, Fumagalli M, Trincavelli ML, Verderio C, Rosa P, Lecca D, Ferrario S, Parravicini C, Capra V, Gelosa P, Guerrini U, Belcredito S, Cimino M, Sironi L, Tremoli E, Rovati GE, Martini C, Abbracchio MP.
    EMBO J; 2006 Oct 04; 25(19):4615-27. PubMed ID: 16990797
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Agonist-induced desensitization/resensitization of human G protein-coupled receptor 17: a functional cross-talk between purinergic and cysteinyl-leukotriene ligands.
    Daniele S, Trincavelli ML, Gabelloni P, Lecca D, Rosa P, Abbracchio MP, Martini C.
    J Pharmacol Exp Ther; 2011 Aug 04; 338(2):559-67. PubMed ID: 21531793
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. CNS remyelination as a novel reparative approach to neurodegenerative diseases: The roles of purinergic signaling and the P2Y-like receptor GPR17.
    Fumagalli M, Lecca D, Abbracchio MP.
    Neuropharmacology; 2016 May 04; 104():82-93. PubMed ID: 26453964
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Olig2-Targeted G-Protein-Coupled Receptor Gpr17 Regulates Oligodendrocyte Survival in Response to Lysolecithin-Induced Demyelination.
    Ou Z, Sun Y, Lin L, You N, Liu X, Li H, Ma Y, Cao L, Han Y, Liu M, Deng Y, Yao L, Lu QR, Chen Y.
    J Neurosci; 2016 Oct 12; 36(41):10560-10573. PubMed ID: 27733608
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. The Orphan Receptor GPR17 Is Unresponsive to Uracil Nucleotides and Cysteinyl Leukotrienes.
    Simon K, Merten N, Schröder R, Hennen S, Preis P, Schmitt NK, Peters L, Schrage R, Vermeiren C, Gillard M, Mohr K, Gomeza J, Kostenis E.
    Mol Pharmacol; 2017 May 12; 91(5):518-532. PubMed ID: 28254957
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. The GPR17 Receptor-A Promising Goal for Therapy and a Potential Marker of the Neurodegenerative Process in Multiple Sclerosis.
    Dziedzic A, Miller E, Saluk-Bijak J, Bijak M.
    Int J Mol Sci; 2020 Mar 08; 21(5):. PubMed ID: 32182666
    [Abstract] [Full Text] [Related]

  • 17. The regulated expression, intracellular trafficking, and membrane recycling of the P2Y-like receptor GPR17 in Oli-neu oligodendroglial cells.
    Fratangeli A, Parmigiani E, Fumagalli M, Lecca D, Benfante R, Passafaro M, Buffo A, Abbracchio MP, Rosa P.
    J Biol Chem; 2013 Feb 15; 288(7):5241-56. PubMed ID: 23288840
    [Abstract] [Full Text] [Related]

  • 18. Frontal affinity chromatography-mass spectrometry useful for characterization of new ligands for GPR17 receptor.
    Calleri E, Ceruti S, Cristalli G, Martini C, Temporini C, Parravicini C, Volpini R, Daniele S, Caccialanza G, Lecca D, Lambertucci C, Trincavelli ML, Marucci G, Wainer IW, Ranghino G, Fantucci P, Abbracchio MP, Massolini G.
    J Med Chem; 2010 May 13; 53(9):3489-501. PubMed ID: 20394377
    [Abstract] [Full Text] [Related]

  • 19. Enigmatic GPCR finds a stimulating drug.
    Harden TK.
    Sci Signal; 2013 Oct 22; 6(298):pe34. PubMed ID: 24150253
    [Abstract] [Full Text] [Related]

  • 20. Identification of novel GPR17-agonists by structural bioinformatics and signaling activation.
    Saravanan KM, Palanivel S, Yli-Harja O, Kandhavelu M.
    Int J Biol Macromol; 2018 Jan 22; 106():901-907. PubMed ID: 28827203
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.